Structure and properties of pharmacologically active polymers
The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Abstract
Although the concept of using pharmacologically active macromolecular compounds as drugs is still regarded with much skepticism for both theoretical and practical reasons, interest in this field has grown in recent years because of the opportunity to take advantage of the specific properties of polymeric materials. For low molecular weight drugs, changes in structure often lead to a loss of specific activity. On the other hand, the properties of macromolecular drugs depend on the structure of the polymer used and this can be varied over a wide range by the incorporation of comonomer units, by the application of polymer‐analogous reactions, or by related structural changes. A new model is presented for pharmacologically active polymers which incorporates the possibility for continuous variation in (a) solubility and toxicity, (b) fixation and removal of active material, and (c) body distribution. Using the new model as a guide, examples of the synthesis and study of the biological activity of various macromolecular drugs are presented in order to emphasize the importance of this cooperative effort between polymer research and therapeutic problems.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The drug-polymer conjugates were introduced in the early work by Helmut Ringsdorf in 1970s to improve drug solubility, toxicity, and body biodistribution, which was followed by extensive studies on the development of drug-polymer conjugates [143, 144].”
From Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval. (2020) · cites this paper as [144]
Citations
Cites
de Duve, C., & Wattiaux, R. (1966) · Annual Review of Physiology · doi:10.1146/annurev.ph.28.030166.002251 · Cited by 3,033
De Duve, C., De Barsy, T., Poole, B., Trouet, A., Tulkens, P., & Van Hoof, F. (1974) · Biochemical Pharmacology · doi:10.1016/0006-2952(74)90174-9 · Cited by 1,901
Chang, T. M. S. (1964) · Science · doi:10.1126/science.146.3643.524 · Cited by 1,011
Lysosomes in Biology and Pathology
Lagunoff, D. (1974) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1974.03230160059035 · Cited by 887
AN EXAMINATION OF THE CYTOTOXIC EFFECTS OF SILICA ON MACROPHAGES
Allison, A. C., Harington, J. S., & Birbeck, M. (1966) · The Journal of Experimental Medicine · doi:10.1084/jem.124.2.141 · Cited by 871
FACTOR-VIII COMPLEX AND ENDOTHELIAL DAMAGE
Boneu, B., Abbal, M., Plante, J., & Bierme, R. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92650-1 · Cited by 716
de Duve, C. (2008) · Novartis Foundation Symposia · doi:10.1002/9780470715314.ch1 · Cited by 473
DRUG-CARRIER POTENTIAL OF LIPOSOMES IN CANCER CHEMOTHERAPY
Gregoriadis, G., Swain, C. P., Wills, E. J., & Tavill, A. S. (1974) · The Lancet · doi:10.1016/s0140-6736(74)90682-5 · Cited by 401
Poly[N-(2-hydroxypropyl)methacrylamide]—I. Radical polymerization and copolymerization
Kopeček, J., & Baẑilová, H. (1973) · European Polymer Journal · doi:10.1016/0014-3057(73)90063-3 · Cited by 300
Ryser, H. J.-P. (1968) · Science · doi:10.1126/science.159.3813.390 · Cited by 288
Research works printed but not linked: 20
- Lee H., 1971, Handbook for Surgery and Artificial Organs
- Kabaiwanow W., 1972, Plaste Kaut., 19, 886
- Wessel W., 1971, Arzeim. Forsch., 21, 1468
- Ryser H. J. P., 1970, Proc. Fourth Int. Cong. Pharm., 3, 96
- 1965, Silikose Forsch., 6, 213
- Ferruti P., 1966, Med. Lav., 57, 481
- V.Hofmann dissertation University of Mainz 1975.
- Burger A., 1970, Medicinal Chemistry, 1185
- Donaruma L. G., 1974, Prog. Polym. Sci., 4, 18
- G.Franzmann dissertation University of Mainz 1975.
- H.Morawetzet al. in press.
- Ringsdorf H., 1967, Strahlentherapie, 132, 627
- Busch H., 1961, Cancer Res., 21, 271
- H.Ritter dissertation University of Mainz 1975.
- M.Przybylski dissertation University of Mainz 1975.
- Jacob S. W., 1971, Dimethylsulfoxide
- V.Hofmann H.Ringsdorf andG.Muacevic Makromol. Chem. in press.
- Jacques P. J., 1966, Rev. Quest. Sci., 27, 99
- Jacques P. J., 1969, Lysosomes in Biology and Pathology, 395
- Szekerke M., 1972, Neoplasma, 19, 211
Cited by
Items 601–700 of 1,000
Perspectives on: Recent Advances in Poly(Amidoamine)s Chemistry
Franchini, J., & Ferruti, P. (2004) · Journal of Bioactive and Compatible Polymers · doi:10.1177/0883911504044453 · Cited by 15
Bispecific antibody complex pre-targeted delivery of polymer–drug conjugates for cancer therapy
Gada, K. S., Patil, V., Panwar, R., Hatefi, A., & Khaw, B. (2012) · Drug Delivery and Translational Research · doi:10.1007/s13346-011-0055-x · Cited by 15
Hofmann, V., Przybylski, M., Ringsdorf, H., & Ritter, H. (1976) · Die Makromolekulare Chemie · doi:10.1002/macp.1976.021770614 · Cited by 15
Self-citationCarboxymethyl poly( L ‐histidine) as a new pH‐sensitive polypeptide at endosomal/lysosomal pH
Asayama, S., Kato, H., Kawakami, H., & Nagaoka, S. (2007) · Polymers for Advanced Technologies · doi:10.1002/pat.890 · Cited by 15
Newell, D. R., Searle, K. M., Westwood, N., & Burtles, S. S. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601106 · Cited by 15
“The original model proposed by Ringsdorf (1975) envisaged a hydrophilic polymer backbone chosen to aid drug solubilisation, a biodegradable polymer– drug linker designed to ensure stability in the circulation, and a targeting ligand to promote tumour-specific delivery.”
MethodSome novel approaches to the design and synthesis of peptide–catecholamine conjugates
Verlander, M. S., Jacobson, K. A., Rosenkranz, R. P., Melmon, K. L., & Goodman, M. (1983) · Biopolymers · doi:10.1002/bip.360220166 · Cited by 15
Immunoconjugates of Soybean Bowman-Birk Protease Inhibitor as Targeted Antitumor Polymeric Agents
Gladysheva, I. P., Moroz, N. A., Анатольевна, К. Т., Nemtsova, E. R., Yakubovskaya, R. I., & Larionova, N. I. (2001) · Journal of drug targeting · doi:10.3109/10611860108998767 · Cited by 15
“Since the introduction of soluble polymers as targetable drug carriers in the mid 1970s (Ringsdorf, 1975), many polymeric drug conjugate systems have been developed and evaluated (Duncan, 1992; Veronese and Morpurgo, 1999).”
BackgroundAbel, G., Connors, T. A., Hofmann, V., & Ringsdorf, H. (1976) · Die Makromolekulare Chemie · doi:10.1002/macp.1976.021770909 · Cited by 15
Self-citationSynthesis and Properties of Hydrophilic Copolymers Containing 5-Fluorouracil, Thymine, or Adenine
Akashi, M., Beppu, K., Kikuchi, I., & Miyauchi, N. (1986) · Journal of Macromolecular Science Part A - Chemistry · doi:10.1080/00222338608069491 · Cited by 15
Tumor-Targeting Theranostic Polymers
Wei, Y., & Wang, M. (2025) · Langmuir · doi:10.1021/acs.langmuir.4c04978 · Cited by 14
Ilayaperumal, P., Megarajan, S., Arunachalam, S., Dhivya, R., Vinothkanna, A., Akbarsha, M. A., & Sekar, S. (2014) · New Journal of Chemistry · doi:10.1039/c4nj00460d · Cited by 14
Nanostructured Polymer Composites for Bio-Applications
Ahmed, T., Saleem, A., Pothu, R., Boddula, R., Gulzar, T., Khan, A., & Asiri, A. M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816771-7.00009-0 · Cited by 14
Journey of Poly(ethylene Glycol) in Living Cells
Yang, J., Li, X., Di, L., Su, Y., & Zhu, X. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c09366 · Cited by 15
Halama, K., Schäffer, A., & Rieger, B. (2021) · RSC Advances · doi:10.1039/d1ra06452e · Cited by 14
Kaufmann, D., & Weberskirch, R. (2006) · Macromolecular Bioscience · doi:10.1002/mabi.200600117 · Cited by 14
pH-sensitive hydrogel containing acetaminophen silyl ethers for colon-specific drug delivery
Mahkam, M., Assadi, M. G., & Golipour, N. (2006) · Designed Monomers & Polymers · doi:10.1163/156855506778944019 · Cited by 14
Anticancer Activity of Cell-Penetrating Redox Phospholipid Polymers
Kaneko, M., Ishikawa, M., Nakanishi, S., & Ishihara, K. (2021) · ACS Macro Letters · doi:10.1021/acsmacrolett.1c00336 · Cited by 14
Eccleston, M., Kaminski, C. F., Slater, N. K. H., & Briggs, M. S. J. (2003) · Polymer · doi:10.1016/j.polymer.2003.10.079 · Cited by 14
Nanotechnology in Drug Delivery: Past, Present, and Future
Kim, S., Kwon, K., Kwon, I. C., & Park, K. (2008) · Springer eBooks · doi:10.1007/978-0-387-77668-2_19 · Cited by 14
“Various conjugates have been developed and clinically tested since the first drug conjugate for cancer therapy was proposed in the middle of 1970 s (Ringsdorf, 1975).”
BackgroundInhibition of Tumor Metastasis by a Synthetic Polymer Containing a Cell-Adhesive RGDS Peptide
Komazawa, H., Saiki, I., Igarashi, Y., Azuma, I., Kojima, M., Orikasa, A., Ono, M., & Itoh, I. (1993) · Journal of Bioactive and Compatible Polymers · doi:10.1177/088391159300800305 · Cited by 14
Prediction of Chemical‐Physical Properties by Neural Networks for Structures
Duce, C., Micheli, A., Solaro, R., Starita, A., & Tinè, M. R. (2006) · Macromolecular Symposia · doi:10.1002/masy.200650203 · Cited by 14
Synthesis and biological activity of phthalimide‐based polymers containing 5‐fluorouracil
Lee, N., Koo, J., Ju, S., Moon, S.-B., Cho, W., Jeong, I., Lee, S., Cho, M., & Theodorakis, E. A. (2002) · Polymer International · doi:10.1002/pi.801 · Cited by 14
pH-Sensitive Polymer–Drug Conjugates
Gillies, E. R. (2024) · Chemistry of Materials · doi:10.1021/acs.chemmater.4c01700 · Cited by 13
Karakuş, G., Ece, A., Yağlıoğlu, A. Ş., Zengin, H. B., & Karahan, M. (2016) · Polymer Bulletin · doi:10.1007/s00289-016-1821-1 · Cited by 13
Jafari, A., Yan, L., Mohamed, M. A., Wu, Y., & Cheng, C. (2020) · Materials · doi:10.3390/ma13071510 · Cited by 14
“The idea of the coupling of drug molecules to a polymer was first introduced by Ringsdorf in 1975, whereby a spacer was used as a linkage between the drug and the polymer [6].”
BackgroundLópez-Donaire, M. L., Sussman, E. M., Fernández‐Gutiérrez, M., Méndez-Vilas, A., Ratner, B. D., Vázquez‐Lasa, B., & Román, J. S. (2012) · Biomacromolecules · doi:10.1021/bm300043f · Cited by 13
Macromolecular nanotheranostics for multimodal anticancer therapy
Veld, R. H. I. '., Storm, G., Hennink, W. E., Kiessling, F. M., & Lammers, T. (2011) · Nanoscale · doi:10.1039/c1nr10733j · Cited by 13
Furoxan‐Bearing Micelles for Nitric Oxide Delivery
Hasegawa, U., Wang, T., Chen, J. J. Y., Uyama, H., & van der Vlies, A. J. (2016) · Macromolecular Bioscience · doi:10.1002/mabi.201500401 · Cited by 13
Dendritic polyglycerol anions for the selective targeting of native and inflamed articular cartilage
Reimann, S., Schneider, T., Welker, P., Neumann, F., Licha, K., Schulze-Tanzil, G. G., Wagermaier, W., Fratzl, P., & Haag, R. (2017) · Journal of Materials Chemistry B · doi:10.1039/c7tb00618g · Cited by 13
Polysaccharide nanoconjugates for drug solubilization and targeted delivery
Kumar, S., Ali, J., & Baboota, S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-08-102553-6.00016-7 · Cited by 13
Narayanan, P., Anitha, A. K., Ajayakumar, N., & Kumar, K. S. (2022) · Materials · doi:10.3390/ma15030800 · Cited by 14
“In this study, we proposed to design and synthesize a fourth generation lysine dendritic nanocarrier based on the concept put forward by Helmut Ringsdorf in 1975 to be utilized as a drug delivery agent to deliver MTX [16].”
MethodAntiinflammatory polymer‐bound steroids for topical applications. I. Synthesis and characterization
Nguyen, K. V., & Galin, J. C. (1985) · Journal of Applied Polymer Science · doi:10.1002/app.1985.070300705 · Cited by 13
Nanoparticles for Cancer Detection and Therapy
Godin, B., Serda, R. E., Sakamoto, J. H., Decuzzi, P., & Ferrari, M. (2010) · Wiley eBooks · doi:10.1002/9783527628155.nanotech051 · Cited by 17
Recent developments in synthetic approaches for macromolecular prodrugs
Alex, J., Weber, C., Guerrero‐Sánchez, C., & Schubert, U. S. (2024) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2024.101855 · Cited by 12
Wang, H., Xiong, Y., Wang, R., Yu, Y., Wang, J., Hu, Z., Sun, C., Tu, J., & He, D. (2018) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2018.04.022 · Cited by 12
Polymeric Nanomaterials: Fundamentals and Therapeutic Applications
Maji, I., Mahajan, S., Sriram, A., Mehra, N. K., & Singh, P. K. (2023) · Springer eBooks · doi:10.1007/978-3-031-30529-0_2 · Cited by 13
Jong, L. D., Moreau, X., Thiéry, A., Godeau, G., Grinstaff, M. W., & Barthélémy, P. (2008) · Bioconjugate Chemistry · doi:10.1021/bc700425x · Cited by 12
Wu, C., Xie, J., Branford‐White, C., Quan, J., & Zhu, L. (2011) · Journal of Applied Polymer Science · doi:10.1002/app.33735 · Cited by 12
Design of a poly( L ‐histidine)‐carbohydrate conjugate for a new pH‐sensitive drug carrier
Asayama, S., Kawakami, H., & Nagaoka, S. (2004) · Polymers for Advanced Technologies · doi:10.1002/pat.493 · Cited by 12
Targeted drug delivery for cancer therapy
Stirland, D. L., Nichols, J. W., Denison, T. A., & Bae, Y. H. (2013) · Elsevier eBooks · doi:10.1533/9780857096760.1.31 · Cited by 15
Venkatraj, N., Nanjan, M. J., Loyer, P., Chandrasekar, M., & Cammas‐Marion, S. (2017) · Journal of Biomaterials Science Polymer Edition · doi:10.1080/09205063.2017.1311294 · Cited by 12
“consists of a polymeric backbone bearing a solubilizer (mainly PEG), a drug (linked through a degradable bond), a targeting molecule and/or a fluorescence probe allowing to follow the biodistribution of the prodrug [5].”
BackgroundLee, W., Wiseman, M. E., Cho, N., Glenn, J. S., & Frank, C. W. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.08.035 · Cited by 12
“It has also been reported that stable release from biodegradable microspheres could be successfully obtained by conjugating the drug to the polymer matrix [10], or by providing an outer layer that surrounds the core unit containing the drug [11].”
BackgroundCai, Q., Zhu, K. J., & Zhang, J. (2005) · Drug Delivery · doi:10.1080/10717540490446107 · Cited by 13
“(Ringsdorf 1975; Davaran, Jalal, and Abbas 1999).”
Mishra, M., Chawla, V., & Chawla, P. A. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.10.069 · Cited by 12
Nanomedicine?, Q. V., Luxenhofer, R., Barz, M., & Schillmeier, M. (2014) · Nanomedicine · doi:10.2217/nnm.14.140 · Cited by 12
Meirim, M. G., Neuse, E. W., & N’Da, D. D. (2001) · Journal of Applied Polymer Science · doi:10.1002/app.2027 · Cited by 12
Application of Materials in Medicine, Biology, and Artificial Organs
Borovetz, H. S., Burke, J. F., Chang, T. M. S., Colas, A., Cranin, A. N., Curtis, J., Gemmell, C. H., Griffith, B. P., Hallab, N. J., Heller, J., et al. (1996) · Elsevier eBooks · doi:10.1016/b978-012582460-6/50010-4 · Cited by 12
2-[N1-2-Pyrimidyl-aminobenzenesulfonamido] ethyl 4-bis(2-chloroethyl) aminophenyl butyrate
Huang, Z. R., Yang, G., Lin, Z., & Huang, J. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00157-3 · Cited by 12
Synthesis, Characterization and Antitumor Activity of Macromolecular Prodrugs of Adriamycin
van Heeswijk, W. A. R., Stoffer, T., Eenink, M. J. D., Potman, W., van der Vijgh, W. J. F., der Poort, J. V., Pinedo, H. M., Lelieveld, P., & Feijén, J. (1984) · Springer eBooks · doi:10.1007/978-1-4613-2745-5_6 · Cited by 12
Synthesis and preliminary biological assessments of RGD bearing biocompatible telomers
Jasseron, S., Contino-Pepin, C., Maurizis, J. C., Rapp, M., & Pucci, B. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)00079-3 · Cited by 12
Poly( L ‐histidine) with several aminoethyl groups for a new pH‐sensitive DNA carrier
Asayama, S., Sekine, T., Hamaya, A., Kawakami, H., & Nagaoka, S. (2005) · Polymers for Advanced Technologies · doi:10.1002/pat.616 · Cited by 12
Braud, C., & Vert, M. (1984) · Springer eBooks · doi:10.1007/978-1-4613-2433-1_1 · Cited by 12
Present and emerging applications of polymeric biomaterials
Hoffman, A. S. (1992) · Clinical Materials · doi:10.1016/0267-6605(92)90025-o · Cited by 13
Hofmann, V., Ringsdorf, H., & Schaumlöffel, E. (1980) · Die Makromolekulare Chemie · doi:10.1002/macp.1980.021810206 · Cited by 12
Self-citationCombinatorial Screening for Specific Drug Solubilizers with Switchable Release Profiles
Wieczorek, S., Vigne, S., Masini, T., Ponader, D., Hartmann, L., Hirsch, A. K. H., & Börner, H. G. (2014) · Macromolecular Bioscience · doi:10.1002/mabi.201400443 · Cited by 11
Peptides as biopolymers—past, present, and future
Ganguly, A., Sharma, K., & Majumder, K. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816897-4.00004-7 · Cited by 15
Avcıbaşı, U., Avcıbaşı, N., Akalın, H. A., Ediz, M., Demiroğlu, H., Gümüşer, G., Özçalışkan, E., Türkcan, C., Uygun, D. A., & Akgöl, S. (2013) · Journal of Nanoparticle Research · doi:10.1007/s11051-013-2021-7 · Cited by 11
“Polymer–drug conjugates were evolved as drug-delivery systems during last decades since Helmut Ringsdorf first proposed the concept of polymer anti-cancer drug conjugates in 1975 (Ringsdorf 1975).”
BackgroundCytotoxicity of hydrophylic silver carboxylato complexes.
Fourie, E., Erasmus, E., Swarts, J. C., Tuchscherer, A., Jakob, A., Lang, H., Joone, G., & van Rensburg, C. E. J. (2012) · PubMed · Cited by 11
Nanocarrier-Assisted Antimicrobial Therapy Against Intracellular Pathogens
Kumar, L., Verma, S., Vaidya, B., & Mehra, N. K. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-46152-8.00013-5 · Cited by 14
Different aspects of polymers – A review article
Bhatt, S., Pathak, A. K., Grover, P., Bharadwaj, A., Bhatia, D., Tomar, R., & Kaurav, M. (2022) · Materials Today Proceedings · doi:10.1016/j.matpr.2022.04.926 · Cited by 15
Berghe, H. V. D., Coudane, J., & Vert, M. (2007) · Journal of Bioactive and Compatible Polymers · doi:10.1177/0883911507084413 · Cited by 11
“Sunamoto et al. [1] was among the pioneers as well as Ringsdorf[2] and the author’s group [3,4], that searched for amphiphilic polymers and polyelectrolytes to temporarily accommodate drug molecules by aggregating hydrophobic pocket-bearing systems.”
BackgroundPreparation and characterization of the poly(2-hydroxyethyl methacrylate)–salicylic acid conjugate
JANTAS, R., & Herczyńska, L. (2009) · Polymer Bulletin · doi:10.1007/s00289-009-0189-x · Cited by 12
Polymeric Prodrugs Containing Metal-Based Anticancer Drugs
Aderibigbe, B. A. (2015) · Journal of Inorganic and Organometallic Polymers and Materials · doi:10.1007/s10904-015-0220-7 · Cited by 11
Magnetic polymeric nanoassemblies for magnetic resonance imaging-combined cancer theranostics
Gan, S., Lin, Y., Feng, Y., Shui, L., Li, H., & Zhou, G. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s164817 · Cited by 11
“Polymeric nanoassemblies in cancer theranostics In 1975, a rational model for pharmacologically active polymers was proposed by Ringsdorf.(9) The Ringsdorf model is primarily aimed at covalently bound polymer–drug conjugates, and consists of three components: a polymeric solubilizer, a drug usually bound to a polymer…”
An Overview of Paclitaxel Delivery Systems
Prabakaran, A., Kar, S., Vignesh, K., & Kolhe, U. D. (2020) · Sustainable agriculture reviews · doi:10.1007/978-3-030-41838-0_6 · Cited by 11
Predictive Platforms of Bond Cleavage and Drug Release Kinetics for Macromolecule–Drug Conjugates
Ghosal, S., Walker, J. E., & Alabi, C. A. (2021) · Annual Review of Chemical and Biomolecular Engineering · doi:10.1146/annurev-chembioeng-091720-030636 · Cited by 11
Biomedical Applications of Polysaccharides
Schuerch, C. (1985) · Springer eBooks · doi:10.1007/978-1-4757-0405-1_14 · Cited by 11
Acid-Sensitive Prodrugs of Doxorubicin
Kratz, F. (2007) · Topics in current chemistry · doi:10.1007/128_2007_5 · Cited by 11
Targeting of Drugs to Cell Surface Receptors
Říhová, B. (1997) · Critical Reviews in Biotechnology · doi:10.3109/07388559709146611 · Cited by 13
Vitamin E as an antioxidant for poly(etherurethane urea):In vivo studies
Schubert, M. A., Wiggins, M. J., DeFife, K. M., Hiltner, A., & Anderson, J. M. (1996) · Journal of Biomedical Materials Research · doi:10.1002/(sici)1097-4636(199612)32:4<493::aid-jbm1>3.0.co;2-m · Cited by 48
Polymeric prodrugs of mitomycin C
Soyez, H., Schacht, E. H., Marre, A. D., & Seymour, L. W. (1996) · Macromolecular Symposia · doi:10.1002/masy.19961030117 · Cited by 11
Design of polyrotaxanes as supramolecular conjugates for cells and tissues
Yui, N., & Ooya, T. (2004) · Journal of Artificial Organs · doi:10.1007/s10047-004-0253-0 · Cited by 11
Deits, W., Vogl, O., & Westhead, E. W. (1981) · Journal of Macromolecular Science Part A - Chemistry · doi:10.1080/00222338108056816 · Cited by 11
Biological Evaluation of Soluble Synthetic Polymers as Drug Carriers
Duncan, R., & Lloyd, J. B. (1984) · Springer eBooks · doi:10.1007/978-1-4613-2745-5_2 · Cited by 11
Present and Emerging Applications of Polymeric Biomaterials
Hoffman, A. S. (1992) · Springer eBooks · doi:10.1007/978-94-011-1872-9_4 · Cited by 11
An insight into cancer nanomedicine based on polysaccharides
Chakraborty, D. D., Chakraborty, P., & Mondal, A. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.138678 · Cited by 12
Exploring the potential of antimalarial nanocarriers as a novel therapeutic approach
Deshmukh, R. (2023) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2023.108497 · Cited by 10
Morrow, J. P., Mazrad, Z. A. I., Warne, N. M., Ayton, S., Bush, A. I., & Kempe, K. (2024) · Biomacromolecules · doi:10.1021/acs.biomac.3c01106 · Cited by 10
Gabriel, D., Zuluaga, M.-F., Martinez, M.-N., Campo, M. A., & Lange, N. (2009) · Journal of Drug Delivery Science and Technology · doi:10.1016/s1773-2247(09)50002-0 · Cited by 10
Synthesis and characterization of polyamidoamine conjugates of neridronic acid
Aderibigbe, B. A., Sadiku, E. R., Ray, S. S., Mbianda, X. Y., Fotsing, M. C. D., Agwuncha, S. C., & Owonubi, S. J. (2014) · Polymer Bulletin · doi:10.1007/s00289-014-1286-z · Cited by 10
“According to Ringsdorf [33], polymer carrier is made up of the polymeric backbone, targeting moiety, solubilizing unit and spacers.”
BackgroundPolymer conjugate of a microtubule destabilizer inhibits lung metastatic melanoma
Yang, R., Mondal, G., Ness, R. A., Arnst, K. E., Mundra, V., Miller, D. D., Li, W., & Mahato, R. I. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.01.028 · Cited by 10
“Polymer-drug conjugates debuted in 1955 [1], and in the mid-1970s Ringsdorf proposed the idea of conjugating therapeutic agents to water soluble polymers [2].”
Cathepsin B-Cleavable Cyclopeptidic Chemotherapeutic Prodrugs
Herceg, V., Bouilloux, J., Janikowska, K., Allémann, É., & Lange, N. (2020) · Molecules · doi:10.3390/molecules25184285 · Cited by 10
“To overcome these drawbacks, macromolecular (mostly polymeric) prodrug systems composed of a scaffold to which an anti-cancer drug is attached were explored [1].”
BackgroundThe Development of Targeted Drug Delivery Systems for Rheumatoid Arthritis Treatment
Rebecca, A. (2012) · InTech eBooks · doi:10.5772/26155 · Cited by 10
Polymer complex of WR 2721. Synthesis and radioprotective efficiency
Koseva, N. S., Tsacheva, I., Mitova, V. A., Vodenicharova, E., Molkentine, J. M., Mason, K. A., & Troev, K. D. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2014.08.006 · Cited by 10
“Synthetic polymer formulations are becoming more and more attractive as delivery vehicles because of the great flexibility regarding: (i) the type and size of the bioactive molecules/agents delivered, (ii) the degree of carrier loading and (iii) the immobilization techniques applied (Duncan, 1992; Hoste et al., 2004;…”
MethodMarre, A. D., Hoste, K., Bruneel, D., Schacht, E. H., & Schryver, F. C. D. (1996) · Journal of Bioactive and Compatible Polymers · doi:10.1177/088391159601100201 · Cited by 13
Enhanced Targeted Drug Delivery Through Controlled Release in a Three-Dimensional Vascular Tree
Zhu, S. J., Poon, E., Ooi, A. S. H., & Moore, S. (2014) · Journal of Biomechanical Engineering · doi:10.1115/1.4028965 · Cited by 10
“Therefore, substantial research efforts have been put in this area [7–10].”
BackgroundPolymer-peptide conjugate hydrogels: towards controlled drug delivery
Sohdi, A. A., Campbell, D., & Topham, P. D. (2012) · Aston Publications Explorer (Aston University) · Cited by 12
Terminology matters: There is no targeting, but retention
Reineke, J. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.01.016 · Cited by 11
Celasun, S., Maron, E., & Börner, H. G. (2019) · Macromolecular Bioscience · doi:10.1002/mabi.201900244 · Cited by 10
Lu, L., Kang, S., Sun, C., Sun, C., Guo, Z., Li, J., Zhang, T., Luo, X., & Liu, B. (2020) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026620666200825170030 · Cited by 10
Historical Introduction to the Field of Controlled Drug Delivery
(2016) · CRC Press eBooks · doi:10.1201/9781315382579-2 · Cited by 12
Rational Design of Multifunctional Polymer Therapeutics for Cancer Theranostics
Ofek, P., Miller, K., Eldar‐Boock, A., Polyak, D., Segal, E., & Satchi‐Fainaro, R. (2010) · Israel Journal of Chemistry · doi:10.1002/ijch.201000020 · Cited by 10
Long-Circulating Polymeric Nanoparticles for Drug and Gene Delivery to Tumors
Kommareddy, S., Shenoy, D. B., & Amiji, M. M. (2006) · CRC Press eBooks · doi:10.1201/9781420006636.ch13 · Cited by 10
Prodrugs and Drug Delivery Systems
Silverman, R. B., Xue, F., & Juncosa, J. I. (2004) · Elsevier eBooks · doi:10.1016/b978-0-08-051337-9.50013-4 · Cited by 10
Polyurethane Nanostructures for Drug Delivery Applications
Rajan, K. P., Thomas, S. P., Gopanna, A., & Chavali, M. S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-52727-9.00016-9 · Cited by 10
Cytotoxicity and Anticancer Activity of Macromolecular Prodrugs of 5-Fluorouracil
Nichifor, M., Schacht, E. H., Seymour, L. W., Anderson, D. W., & Shoaibi, M. A. (1997) · Journal of Bioactive and Compatible Polymers · doi:10.1177/088391159701200401 · Cited by 10
Oyama, T., Kawamura, M., Abiko, T., Izumi, Y., Watanabe, M., Kumazawa, E., Kuga, H., Shiose, Y., & Kobayashi, K. (2007) · Oncology Reports · doi:10.3892/or.17.3.653 · Cited by 10
In vitro antitrichomonal activity of water-soluble prodrug esters of metronidazole
VERMEERSCH, H., Remon, J. P., Permentier, D., & Schacht, E. H. (1990) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(90)90079-j · Cited by 10
Maree, M. D., Neuse, E. W., Erasmus, E., & Swarts, J. C. (2007) · Metal-Based Drugs · doi:10.1155/2008/217573 · Cited by 10
“Although models as those mentioned above for synthetic polymeric drug carriers have been in existence for some time [24], until recently only a few efforts were made to actually prepare such compounds.”
BackgroundLong acting thrombolytic immobilized enzymes
Torchilin, V. P., & Mazaev, A. V. (1985) · Journal of Controlled Release · doi:10.1016/0168-3659(85)90054-9 · Cited by 10
Metadata
- Authors
- Ringsdorf, H.
- Affiliations
- Johannes Gutenberg University Mainz (DE)
- Corresponding author
- Ringsdorf, Helmut
- Venue
- Journal of Polymer Science: Polymer Symposia
- Publisher
- Wiley
- Published
- 1975-01
- Volume
- 51
- Issue
- 1
- Pages
- 135-153
- ISSN
- 0360-8905 (ISSN-L)
- 1936-0959
- OpenAlex
- W2098279377
- Cited by
- 1,094
- References
- 63
- Citations by year
- 2026: 8 · 2025: 10 · 2024: 34 · 2023: 35 · 2022: 30 · 2021: 35 · 2020: 50 · 2019: 36 · 2018: 29 · 2017: 46 · 2016: 45 · 2015: 47 · 2014: 55 · 2013: 43 · 2012: 48
- FWCI
- 6.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Polymer Science Polymer Symposia (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Physical Sciences › Chemistry › Organic Chemistry › Advanced Polymer Synthesis and Characterization
- Physical Sciences › Materials Science › Biomaterials › Hydrogels: synthesis, properties, applications
- Keywords
- macromolecular drugs, comonomer incorporation, polymer-analogous reactions, solubility, toxicity, body distribution, polymer synthesis, biological activity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.